An experimental twice-yearly injection called zilebesiran shows promise in treating high blood pressure by blocking a liver protein to relax blood vessels.
← News
Tech for Good Tech for Good Frontiers
Forget daily pills. This shot works when blood pressure meds fail
Twice Yearly Treatment frequency
Zilebesiran Drug name
Blocks Liver Protein Mechanism
Outperforms Standard Therapy Efficacy
Greater Reductions Vs Standard Therapy improvement
2 Injections/Year treatment frequency